Secondary Schizophrenia (54 page)

1998.
31
(3):131–7.

schizophrenia. Br J Psychiatry,

cocaine intoxication and acute

17. Tatetsu S. Methamphetamine

1965.
111
:701–7.

schizophrenia at emergency

psychosis. Folia Psychiatr Neurol

27. Ellinwood E. H., Jr. Amphetamine

presentation. Schizophr Bull, 1999.

Jpn Suppl, 1963.
7
:377–80.

psychosis: I. Description of the

25
(2):387–94.

18. Barr A. M., Panenka W. J.,

individuals and process. J Nervous

9. Shaner A., Roberts L. J., Eckman

MacEwan G. W.,
et al.
The need

Mental Disease, 1967.
144
:
T. A.,
et al.
Sources of diagnostic

for speed: an update on

273–83.

uncertainty for chronically

methamphetamine addiction.

28. Charles-Nicolas A. J. [Does

psychotic cocaine abusers.

J Psychiatry Neurosci, 2006.

chronic psychosis due to

Psychiatr Serv, 1998.

31
(5):301–13.

amphetamines abuse exist? Study

49
(5):684–90.

19. Iyo M., Namba H., Yanagisawa M.,

of 25 drug addicts.] Nouv Presse

10. Sato M., Chen C. C., Akiyama K.,

et al.
Abnormal cerebral perfusion

Med, 1976.
5
(37):2447–50.

137

Otsuki S. Acute exacerbation of

in chronic methamphetamine

French.

Organic Syndromes of Schizophrenia – Section 3

29. Yui K., Ikemoto S., Ishiguro T.,

review. Br J Psychiatry, 2004.

substance use disorders. Schizophr

Goto K. Studies of amphetamine

185
:196–204.

Bull, 1997.
23
(2):187–93.

or methamphetamine psychosis

39. Gawin F. H. Cocaine addiction:

49. Bartlett E., Hallin A., Chapman B.,

in Japan: relation of

psychology and neurophysiology.

Angrist B. Selective sensitisation

methamphetamine psychosis to

Science, 1991.
251
(5001):
to the psychosis inducing effects

schizophrenia.] Ann NY Acad Sci,

1580–6.

of cocaine: a possible marker for

2000.
914
:1–12.

addiction relapse vulnerability?

40. Segal D. S., Kuczenski R.

30. Goto, T. [Clinical pictures shown

Neuropsychopharmacology, 1997.

Behavioral alterations induced by

by long hospitalized cases of

16
(1):77–82.

an escalating dose-binge pattern

chronic methamphetamine

of cocaine administration. Behav

50. Reid M. S., Ciplet D., O’Leary S.,

psychosis: a comparative study

Brain Res, 1997.
88
(2):251–60.

Branchey M., Buydens-Branchey

with schizophrenia.] Psychiatr

L. Sensitisation to the psychosis-

Neurol Jpn, 1960.
62
:163–76.

41. Flaum M., Schultz S.K. When

inducing effects of cocaine

Japanese.

does amphetamine-induced

compared with measures of

31. Utena, H., Takano S., Yuasa S.,

psychosis become schizophrenia?

cocaine craving and cue reactivity.

Shimizu T., Kato T. Behavioral

Am J Psychiatry, 1996.
153
(6):
Am J Addict, 2004.
13
(3):
abnormalities in animals and

812–5.

305–15.

metabolic changes in the brain.

42. Post R. Cocaine psychoses: a

51. Unnithan S. B., Cutting J. C. The

No To Shinkei, 1961.
13
:
continuum model. Am J

cocaine experience: refuting the

687–95.

Psychiatry, 1975.
132
(3):
concept of a model psychosis?

32. Utena H. Behavioral aberrations

225–31.

Psychopathology, 1992.
25
(2):
in methamphetamine-intoxicated

43. Satel S. L., Edell W. S.

71–8.

animals and chemical correlates

Cocaine-induced paranoia and

52. Pencer A., Addington J. Substance

in the brain. Prog Brain Res, 1966.

psychosis proneness. Am J

use and cognition in early

21
:192–207.

Psychiatry, 1991.
148
(12):
psychosis. J Psychiatr Neurosci,

33. Tomiyama C. Chronic

1708–11.

2003.
28
(1):48–54.

schizophrenia-like states in

44. Thirthalli J., Benegal V. Psychosis

methamphetamine psychosis.

53. Iwanami A., Kuroki N., Iritani S.,

among substance users. Curr

Jpn J Psychiatr Neurol, 1990.

et al.
P3a of event-related

Opin Psychiatry, 2006.
19
(3):
44
(3):531–9.

potential in chronic

239–45.

methamphetamine dependence.

34. Srisurapanont M., Ali R., Marsden

45. Rounsaville B. J., Anton S. F.,

J Nerv Ment Dis, 1998.
186
(12):
J.
et al.
Psychotic symptoms in

Carroll K.,
et al.
Psychiatric

746–51.

methamphetamine psychotic

diagnoses of treatment-seeking

in-patients. Int J Neuropsycho-

54. Iwanami A., Suga I., Kaneko T.,

cocaine abusers. Arch Gen

pharmacol, 2003.
6
(4):347–52.

Sugiyama A., Nakatani Y. P300

Psychiatry, 1991.
48
(1):
component of event-related

35. Chen C. K., Lin S. K., Sham P. C.,

43–51.

potentials in methamphetamine

et al.
Morbid risk for psychiatric

46. McLellan A. T., Woody C. E.,

psychosis and schizophrenia.

disorder among the relatives of

O’Brien C. P. Development of

Prog Neuropsychopharmacol Biol

methamphetamine users with and

psychiatric illness in drug abusers:

Psychiatry, 1994.
18
(3):
without psychosis. Am J Med

possible role of drug preference.

465–75.

Genet B Neuropsychiatr Genet,

N Eng J Med, 1979.
301
:1310–14.

2005.
136
(1):87–91.

55. Iwanami, S. A., Kanamori, R.

47. Rosse R. B., Collins Jr,

Suga, I. Kaneko, T., Kamijima, K.

36. Askevold F. The occurrence of

Fay-McCarthy M.,
et al.

Reduced attention-related

paranoid incidents and abstinence

Phenomenologic comparison of

negative potentials in

delirium in abusers of

the idiopathic psychosis of

methamphetamine psychosis.

amphetamine. Acta Psychiatr

schizophrenia and drug-induced

J Nerv Ment Dis, 1995.
183
(11):
Scand, 1959.
34
:145–64.

cocaine and phencyclidine

693–7.

37. Wetli C. V., Fishbain D. A.

psychoses: a retrospective study.

56. Fein G., Biggins C., MacKay S.

Cocaine-induced psychosis and

Clin Neuropharmacol, 1994.

Cocaine abusers have reduced

sudden death in recreational

17
(4):359–69.

auditory P50 amplitude and

cocaine users. J Forensic Sci, 1985.

48. Rosenthal R. N., Miner C. R.

suppression compared to both

30
(3):873–80.

Differential diagnosis of

normal controls and alcoholics.

38. Curran C., Byrappa N., McBride

substance-induced psychosis and

Biol Psychiatry, 1996.
39
(11):
138

A. Stimulant psychosis: systematic

schizophrenia in patients with

955–65.

Chapter 9 – Stimulants and psychosis

57. Adler L. E., Olincy A., Cawthra R.

65. White F. J., Kalivas P. W.

cognitive and emotional

N.,
et al.
Reversal of diminished

Neuroadaptations involved in

behaviors in mice. Mol Psychiatry,

inhibitory sensory gating in

amphetamine and cocaine

2005.
10
(3):299–308.

cocaine addicts by a nicotinic

addiction. Drug Alcohol Depend,

74. McNeil T. F., Cantor-Graae E.,

cholinergic mechanism.

1998.
51
(1–2):141–53.

Ismail B. Obstetric complications

Neuropsychopharmacology, 2001.

66. Robinson T. E., Kolb B. Structural

and congenital malformation in

24
(6):671–9.

plasticity associated with

schizophrenia. Brain Res Brain

58. Boutros N. N., Lisanby H. S.,

exposure to drugs of abuse.

Res Rev, 2000. 31(2–3):166–78.

Tokuno H.,
et al.
Elevated motor

Neuropharmacology, 2004.
47

75. Ellison G. Stimulant-induced

threshold in drug-free,

Suppl 1:33–46.

psychosis, the dopamine theory of

cocaine-dependent patients

67. Kalivas P. W., Hu X. T. Exciting

schizophrenia, and the habenula.

assessed with transcranial

inhibition in psychostimulant

Brain Res Brain Res Rev, 1994.

magnetic stimulation. Biol

addiction. Trends Neurosci, 2006.

19
(2):223–39.

Psychiatry, 2001.
49
(4):
29
(11):610–6. [Epub Sept. 7,
76. Beresford T. P., Clapp L. Martin

369–73.

2006.]

B.,
et al.
Aripiprazole in

59. Boutros N. N., Lisanby S. H.,

68. Strakowski S. M., Sax K. W.,

schizophrenia with cocaine

McClain-Furmanski D.,
et al.

Setters M. J., Stanton S. P., Keck P.

dependence: a pilot study. J Clin

Cortical excitability in

E. Jr. Lack of enhanced response

Psychopharmacol, 2005.

cocaine-dependent patients: a

to repeated d-amphetamine

25
(4):363–6.

replication and extension of TMS

challenge in first-episode

77. Green A. I., Tohen M. F., Hamer

findings. J Psychiatr Res, 2005.

psychosis: implications for a

R. M.,
et al.
First episode

39
(3):295–302.

sensitisation model of psychosis

schizophrenia-related psychosis

60. Bramon E., Rabe-Hesketh S.,

in humans. Biol Psychiatry, 1997.

and substance use disorders: acute

Sham P., Murray R. M., Frangou S.

42
(9):749–55.

response to olanzapine and

Meta-analysis of the P300 and P50

69. Boileau I., Dagher A., Leyton M.,

haloperidol. Schizophr Res, 2004.

waveforms in schizophrenia.

et al.
Modeling sensitisation to

66
(2–3):125–35.

Schizophr Res, 2004.
70
(2–3):
stimulants in humans: an

78. Brown E. S., Nejtek V. A., Perantie

315–29.

[11C]raclopride/positron

D.C., Rajan Thomas N., Rush A. J.

61. Sundaresan K., Ziemann U.,

emission tomography study in

Cocaine and amphetamine use in

Stanley J., Boutros N. N. Cortical

healthy men. Arch Gen Psychiatry,

patients with psychiatric illness: a

inhibition and excitation in

2006.
63
(12):1386–95.

randomized trial of typical

abstinent cocaine-dependent

70. Brady K. T., Lydiard R. B.,

antipsychotic continuation or

patients: a transcranial magnetic

Malcolm R., Cocaine-induced

discontinuation. J Clin

stimulation study. Neuro Report.

psychosis. J Clin Psychiatry, 1991.

Psychopharmacol, 2003.

(In Press.)

52
(12):509–12.

23
(4):384–8.

62. Wiesbeck G. A., Taeschner K. L. A